JP Morgan Chase’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1K Buy
17,950
+4,123
+30% +$3.04K ﹤0.01% 6711
2025
Q4
$9.84K Buy
13,827
+13,308
+2,564% +$18.1K ﹤0.01% 6680
2025
Q3
$841 Buy
+519
New +$523 ﹤0.01% 6997
2025
Q2
Sell
-2,258,512
Closed -$1.29M 7642
2025
Q1
$1.29M Sell
2,258,512
-2,897,084
-56% -$2.86M ﹤0.01% 4176
2024
Q4
$7.37M Buy
5,155,596
+5,130,774
+20,670% +$11.5M ﹤0.01% 3003
2024
Q3
$47.9K Buy
24,822
+661
+3% +$1.87K ﹤0.01% 6008
2024
Q2
$74.9K Buy
24,161
+5,232
+28% +$21.6K ﹤0.01% 5678
2024
Q1
$99K Sell
18,929
-10,927
-37% -$52.3K ﹤0.01% 5683
2023
Q4
$96.7K Sell
29,856
-8
-0% -$17 ﹤0.01% 5745
2023
Q3
$76.2K Sell
29,864
-5,821
-16% -$24.4K ﹤0.01% 5638
2023
Q2
$209K Buy
35,685
+1,017
+3% +$5.91K ﹤0.01% 5046
2023
Q1
$99K Buy
34,668
+17,351
+100% +$48.8K ﹤0.01% 5438
2022
Q4
$35K Buy
17,317
+21
+0.1% +$51 ﹤0.01% 5726
2022
Q3
$50K Buy
17,296
+617
+4% +$2.88K ﹤0.01% 5551
2022
Q2
$94K Sell
16,679
-5,197
-24% -$42K ﹤0.01% 5440
2022
Q1
$258K Buy
21,876
+9,647
+79% +$117K ﹤0.01% 5056
2021
Q4
$232K Buy
12,229
+5,503
+82% +$120K ﹤0.01% 5272
2021
Q3
$139K Buy
+6,726
New +$145K ﹤0.01% 5407

Other funds holding TNYA

JP Morgan Chase's TNYA Position: Q1 2026 in Review

JP Morgan Chase increased its Tenaya Therapeutics (TNYA) stake by 30% in Q1 2026, buying an estimated $3.04K and bringing the position to 17,950 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6711.

JP Morgan Chase first reported a position in TNYA in Q3 2021 and has held it in 18 quarters since. The position peaked at $7.37M in Q4 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • JP Morgan Chase held 17,950 shares of Tenaya Therapeutics worth $11.1K as of Q1 2026.
  • JP Morgan Chase bought 4,123 Tenaya Therapeutics shares in Q1 2026, an estimated $3.04K.
  • Tenaya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6711 holding.
  • JP Morgan Chase first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's Tenaya Therapeutics position peaked at $7.37M in Q4 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.